With December ticking toward its end, 2024 is just about ready to fall off the calendar. It's been an absolutely wonderful ...

In May 2024, the European Commission granted Marketing Authorization for LYTENAVA for the treatment of wet AMD in the EU. Additionally, in July 2024, the UK Medicines and Healthcare products ...

Outlook Therapeutics ( ($OTLK) ) has released its Q4 earnings. Here is a breakdown of the information Outlook Therapeutics presented to its ...